Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151 USD | -0.20% | -0.35% | -3.75% |
11:46am | J&J: positive trial for Tremfya in ulcerative colitis | CF |
11:41am | Valneva Names New Chief Scientific Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.75% | 364B | |
+37.87% | 705B | |
+32.82% | 583B | |
+19.77% | 332B | |
+5.05% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.93% | 169B | |
-0.91% | 162B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate